Sufficient medicine raw materials, formulations available to meet coronavirus outbreak: NPPA

The National Pharmaceutical Pricing Authority (NPPA) on Thursday assured that there is sufficient stock of raw materials for medicines and formulations available to meet requirements of the situation arising due to the coronavirus outbreak.

NPPA Chairman Shubhra Singh met representatives of pharmaceutical industry associations on the issue of availability of critical active pharmaceutical ingredients (APIs).

"Chairman NPPA met today representatives of the Pharma Associations on the issue of availability of critical APIs. It is assured that sufficient stock of critical APIs and formulations is available to meet the requirements of the situation arising out of COVID-19," the drug pricing authority said in a tweet.

It further said, "Indian Drug Manufacturers' Association (IDMA) has assured NPPA regarding enough stock of APIs and formulations. No shortages in the near future."